Edwards Lifesciences (NYSE: EW), is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. We thrive on discovery and expanding the boundaries of medical technology, serving patients in 100+ countries, with the help of our employees in areas including Clinical Affairs, Quality Engineering, Research & Development, Regulatory Affairs, Sales & Marketing, corporate functions and more. Contact Us We want to hear from you and engage in meaningful discussions. However, please note that we are not equipped to provide customer, candidate, or technical support through this platform. If you require assistance from those teams, please find their contact information here: https://www.edwards.com/aboutus/contactus If you’re a patient in need of medical advice, please contact your healthcare provider directly. We reserve the right to remove any comments that are off-topic, repetitive, or include hate speech, profanity, or offensive language. Additionally, we will not engage in discussions about competitor products, off-label use of Edwards products, or unsubstantiated/misleading claims that could cause harm. All Terms and Conditions of LinkedIn apply. For the Edwards Lifesciences privacy policy, visit https://www.edwards.com/legal/privacypolicy.
Unlock the market timeline & signal feed
415 signals in the last 90 days.
The order this company entered each market — oldest to newest
Discover your next job opportunity in Pune, India
Join our growing IT teams in Pune, India
Sign up to see the full signal feed
How Edwards Lifesciences's international expansion compares to its competitors
Edwards LifesciencesYouBars show relative size across the companies compared.
5 metrics| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 Edwards LifesciencesYou | 38 | 0 | +14% | 390 | 32 |
Scaling fast — 461 roles opened in the last 90 days, up 197% vs the prior period. Sales-led and concentrated in France.
Pune City, Maharashtra, India · 2d ago
Engineer II, AI/Machine Learning
Pune City, Maharashtra, India · 2d ago
Engineer II, AI/Machine Learning
Greater Metz Area · 2d ago
Field Clinical Specialist, Mitral Therapies - Région Nord Est
59 technologies detected across the stack.
4 active campaigns across 40 markets.
Active
Active
Active3 mentions in the last 90 days.
Shanghai Deda Cardiovascular Hospital strengthens international academic exchanges with global experts and expands domestic collaborations through training programs, technical partnerships, and charity initiatives across China.
Edwards Lifesciences successfully completed first tricuspid regurgitation treatments in Hong Kong using PASCAL Precision system, expanding beyond mitral valve applications launched in 2025.
Edwards Lifesciences presented 10-year COMMENCE trial results showing 97.9% freedom from structural valve deterioration with RESILIA tissue, supporting long-term durability for over 500,000 patients worldwide.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Edwards Lifesciences's business, markets, and growth signals.
“We reach accounts the week they land in-market — not the quarter after.”
Book a walkthrough of the movement map with our team.
Pubrio turns expansion signals across 200+ markets into one live graph, so revenue teams see which companies are entering new markets, and act on the timing.
© 2026 Pubrio. All rights reserved.
